Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372515
Status:
COMPLETED
Last Update Posted:
2018-01-31
First Post:
2006-09-06
Brief Title:
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Sponsor:
David M Jackman MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
05-403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
David M Jackman MD
Lead Sponsor Class:
OTHER
Responsible Party:
David M Jackman MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Massachusetts General Hospital | OTHER |
| AstraZeneca | INDUSTRY |